Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
9.00
+0.08 (0.90%)
Dec 3, 2024, 10:00 AM EST - Market open
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $175.78 million as of December 3, 2024.
Market Cap
175.78M
Enterprise Value
160.70M
1-Year Change
n/a
Ranking
Category
Stock Price
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has increased from $152.13M to $175.78M, an increase of 15.55%. That is a compound annual growth rate of 60.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2024 | 174.22M | 14.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pro-Dex | 166.23M |
| Fennec Pharmaceuticals | 166.21M |
| Organigram Holdings | 165.86M |
| PepGen | 164.61M |
| Atossa Therapeutics | 163.54M |
| EUDA Health Holdings | 158.35M |
| Gossamer Bio | 158.19M |
| Candel Therapeutics | 152.80M |